Market Overview

UPDATE: Baird Downgrades Pieris Pharmaceuticals To Neutral, Announces $5 Target As Firm Notes 'Recent performance has fairly valued PIRS shares, in our view, ahead of upcoming Phase 1b PRS-060 data for PRS-060 in asthma'

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for PIRS

DateFirmActionFromTo
Jul 2019DowngradesOutperformNeutral
May 2019Initiates Coverage OnOutperform
May 2018Initiates Coverage OnOutperform

View More Analyst Ratings for PIRS
View the Latest Analyst Ratings

Posted-In: Analyst Color News Downgrades Price Target Analyst Ratings

 

Related Articles (PIRS)

Latest Ratings

StockFirmActionPT
MUCascendReiterates65.0
ALDRCanaccord GenuityDowngrades20.0
LEGHLake StreetInitiates Coverage On21.0
CHUGoldman SachsUpgrades13.2
STZBMO CapitalMaintains230.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Two Texas Truckers And A State Worker Sold Hundreds Of Fake Commercial Driver's Licenses

Wabtec Lowers Its Sales Expectations For 2019